Regulatory-grade evidence must reflect the true patient experience across care settings over time, supported by transparent, reproducible, and well-governed processes. John Snow Labs’ PJI platform ...
By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...
This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...
Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...
OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that this month it has successfully delivered an anonymized Real-World ...
In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...
Venetoclax shows similar efficacy and safety in real-world settings and clinical trials for CLL treatment, with a 94% overall response rate. Real-world studies provide insights into diverse patient ...
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 ...
Until recently, the most effective protection against respiratory syncytial virus (RSV) was only available for high-risk infants, and many parents and providers may remember the vulnerability that ...
The National Institute on Aging has launched a $27.2 million initiative to create a unified network aimed at accelerating Alzheimer’s and dementia research. The five-year project — titled “Using ...
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results